Jasper finds new purpose in merger with Kira, while offloading Tavneos rival to Mirador July 17, 2026Posted inBiotechnology Jasper Therapeutics is being reborn via a merger with Nasdaq-listed immune-mediated disease biotech Kira Pharmaceuticals. Post navigation Previous Post Repetitive Neuronal Stimulation Reprograms Mature Neurons Into Immature StatesNext PostExtracellular Matrix Stiffness Guides Region-Specific Lung Epithelial Differentiation in Organoids
